Dr. Sanghoon Moon, Head of R&D center of Hancom Carelink, focusing on the population genetics study, expressed his expectation for MGI's sequencing products in advancing Korean genome scientific research and clinical applications.

According to Dr. Moon, the DNBSEQ-T7 will play a pivotal role in the national whole genome sequencing project, while the DNBSEQ-G400 will be instrumental in studying the microbiome and conducting genetic tests for the Korean population.

We are excited to part of Korean national project and really looking forward to the remarkable advancements and discoveries that MGI's cutting-edge sequencing technology will enable!